Revive Therapeutics Ltd
CNSX:RVV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revive Therapeutics Ltd
CNSX:RVV
|
CA |
Intrinsic Value
The intrinsic value of Revive Therapeutics Ltd (RVV) under the Base Case is 0.05 CAD per share. Compared with the current market price of 0.02 CAD, the stock appears Undervalued by 57% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Revive Therapeutics Does
Revive Therapeutics Ltd. is a development-stage biotechnology company that tries to turn existing drugs into new treatments for serious medical conditions. Its work centers on testing repurposed medicines and psychedelic-based therapies for areas such as infectious disease, inflammation, and mental health, where doctors still need better options. It does not run a broad consumer business; its main product is a pipeline of drug programs that are still being studied and advanced through the clinical and regulatory process.
- Headquarters
- Canada CA
- IPO date
- Jul 12, 2013
Revenue & Expenses Breakdown
Revive Therapeutics Ltd
Earnings Waterfall
Revive Therapeutics Ltd
The intrinsic value for Revive Therapeutics Ltd (RVV) under the Base Case is 0.05 CAD.
Compared with the current market price of 0.02 CAD, the stock appears Undervalued by 57% .